Tripos Awarded NIH Grant to Develop Technology for Drug Discovery

Tripos, a provider of drug discovery chemistry and informatics products and services, has been awarded an $860,000 Phase II Small Business Innovation Research grant from the NIH.

Tripos will use this two-year grant to create a full-scale library design system for use directly by medicinal chemists at its research facility, Tripos Discovery Research Centre. Based on topomer technology, this proprietary system will have the capacity to search a million times more structures than previously possible, providing a richer universe of synthetic chemistries.

Scientists will be able to extend their knowledge of similar molecules, resulting in improved success rates for all stages of drug discovery. This system also has the potential to be licensed to other drug discovery research operations under the appropriate technology transfer agreements.